首页 | 本学科首页   官方微博 | 高级检索  
检索        

有晶状体眼后房散光型IOL植入矫正高度近视散光
引用本文:贺温玲,刘欣华,孙良南.有晶状体眼后房散光型IOL植入矫正高度近视散光[J].国际眼科杂志,2012,12(12):2387-2389.
作者姓名:贺温玲  刘欣华  孙良南
作者单位:中国广东省深圳市眼科医院;中国广东省深圳市眼科医院;中国广东省深圳市眼科医院
摘    要:目的:评价有晶状体眼后房散光型人工晶状体(TICL)植入术矫治高度近视散光的临床效果。

方法:选自2009-10/2011-11接受TICL植入的高度近视散光患者30例50眼,术前平均屈光度球镜-10.75±2.65D,柱镜-2.85±0.75D。随访观察术后3mo~2a裸眼视力、最佳矫正视力、屈光度、内皮细胞计数等情况,分析并发症的发生情况。

结果:术后裸眼视力:0.5~1.2(平均0.75±0.34)。术前最佳矫正视力:0.3~1.0(平均0.58±0.35),术后最佳矫正视力0.6~1.2(平均0.78±0.35)。达到术前矫正视力20眼(40%),超过术前最佳矫正视力30眼(60%),随访3mo~2a,视力无明显变化。术后屈光度数平均球镜-0.52±0.35D,柱镜0.52±0.25D。角膜内皮细胞计数术前3 026±250个/mm2,术后3mo为3 023±246个/mm2,差异无统计学意义(P<0.05)。未见严重影响视力的并发症。

结论:TICL植入矫治高度近视散光安全有效,是高度近视散光患者的理想治疗方法。对眼内的长期影响需要进一步观察。

关 键 词:高度近视散光    后房散光型人工晶状体    有晶状体眼
收稿时间:2012/8/16 0:00:00
修稿时间:2012/11/7 0:00:00

Clinical study of the implantation of phakic posterior chamber Toric intraocular lens for high myopia with astigmatism
Wen-Ling He,Xin-Hua Liu and Liang-Nan Sun.Clinical study of the implantation of phakic posterior chamber Toric intraocular lens for high myopia with astigmatism[J].International Journal of Ophthalmology,2012,12(12):2387-2389.
Authors:Wen-Ling He  Xin-Hua Liu and Liang-Nan Sun
Institution:Shenzhen Eye Hospital, Shenzhen Ophthalmic Center of Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China;Shenzhen Eye Hospital, Shenzhen Ophthalmic Center of Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China;Shenzhen Eye Hospital, Shenzhen Ophthalmic Center of Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China
Abstract:AIM: To assess the clinical outcome of the implantation of phakic posterior chamber Toric intraocular lens(TICL)for high myopia with astigmatism.

METHODS: Totally 50 eyes of 30 patients with high myopia and astigmatism were treated with TICL implantation from October 2009 to November 2011. The preoperative mean spherical equivalent was -10.75±2.65D, the mean cylindrical equivalent was -2.85±0.75D. All of the patients were followed up for 3 months to 2 years. Uncorrected and best-corrected visual acuity, refraction, intraocular pressure and endothelial cell morphometry, as well as the complications were observed.

RESULTS: The range of uncorrected visual acuity after operation was 0.5-1.2, mean 0.75±0.34. The range of preoperative best-corrected visual acuity was 0.3-1.0, mean 0.58±0.35. The mean best-corrected visual acuity after operation was 0.78±0.35. The uncorrected visual acuity after operation of 20 eyes was same and of 30 eyes was better than the preoperative best-corrected visual acuity. The mean spherical equivalent after operation was -0.52±0.35D, the mean cylindrical equivalent was 0.52±0.25D. Corneal endothelium counting before and after the operation had no significant difference. No serious complication was detected during the follow-up.

CONCLUSION: The implantation of phakic posterior chamber TICL for high myopia with astigmatism is safe and effective. It is a suitable treatment method for high myopia.

Keywords:high myopia with astigmatism  posterior chamber Toric intraocular lens  phakic
点击此处可从《国际眼科杂志》浏览原始摘要信息
点击此处可从《国际眼科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号